KLRK1 and neoplasm: Despite being less frequently found in the tumor and ascites (Figure 5H), NK cells in tumors displayed significantly increased expression of activating markers such as NK1.1, NKp46, and CD69, but not LAG3 nor NKG2D (Figure 6B).